Cannabis Buisness

Why Tilray Can’t Count on Cannabis For Now

Why Tilray Can’t Count on Cannabis For Now

© Provided by The Motley Fool Why Tilray Can’t Count on Cannabis For Now Tilray Brands (NASDAQ: TLRY), an international beverage, wellness, and cannabis company, has recently made major acquisitions that expanded its Canadian, US, and European cannabis...

CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge

You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.

All the Outcomes of a Marijuana Reschedule

All the Outcomes of a Marijuana Reschedule

Between LinkedIn, Twitter, the media, and diehard marijuana investors, there is more noise and froth in the industry about a marijuana reschedule than I’ve seen since Washington and Colorado legalized it back in 2012. When speculation about the Feds starts to explode...